Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909–19.
Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985;8433:829–32.
Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Followup after 11 years update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat. 1997;45:263–70.
Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening–—reliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat. 1991;18:49–56.
Bjurstam N, Björneld L, Warwick J, Sala E, Duffy SW, Nyström L, et al. The Gothenburg breast screening trial. Cancer. 2003;97:2387–96.
Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst. 2000;92:1490–9.
Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305–12.
Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet. 2006;36:2053–60.
Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst. 1986;77:317–32.
Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 1999;353:1903–8.
Kanemura S, Tsuji I, Ohuchi N, Takei H, Yokoe T, Koibuchi Y, et al. A case control study on the effectiveness of breast cancer screening by clinical breast examination in Japan. Jpn J Cancer Res. 1999;6:607–13.
Sasa M, Morimoto T, Yamaguchi T, Kondo H, Kuroda R, Mitsuyama M, et al. Breast cancer screening by palpation and mammography: simultaneous or consecutive examination? J Jpn Assoc Breast Cancer Screen. 1999;8:11–4.
US Preventive Services Task Force. Screening for breast cancer. U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716–26.
Suzuki A, Kuriyama S, Kawai M, Amari M, Takeda M, Ishida T, et al. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci. 2008;99:2264–7.
Morimoto T, Tangoku A, Yamakawa T, Tsuruno M, Takashima S. Promotion of quality-controlled mammography alone as a screening modality in Japan. Breast Cancer 2012; 23 (published online).
Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999;282:1270–80.
Oestreicher N, Lehman CD, Seger DJ, Buist DS, White E. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR. 2005;184:428–32.
Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, Key CR, Linver MN. Effect of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque. New Mexico. Radiology. 1998;209:511–8.
Peer PG, Verbeek AL, Straatman H, Hendriks JH, Holland R. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat. 1996;38:153–60.
Chiarelli AM, Majpruz V, Brown P, Thériault M, Shumak R, Mai V. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst. 2009;101:1236–43.
Ohuchi N, Ishida T, Kawai M, Narikawa Y, Yamamoto S, Sobue T. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40–49 (J-START): research design. JPN J Clin Oncol. 2011;41:275–7.
Caldarella A, Puliti D, Crocetti E, Bianchi S, Vezzosi V, Apicella P. Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening. J Cancer Res Clin Oncol. 2013;139:181–5.